Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous vein

Journal of Cardiovascular Pharmacology

Volumn 35, Issue 4, 2000, Pages 531-537

  Stanke Labesque, Françoise ^a,c   Cracowski, Jean Luc ^a   Bedouch, Pierrick ^a   Chavanon, Olivier ^b   Magne, Jean Luc ^b   Bessard, Germain ^a   Devillier, Philippe ^a  

^a UNIV GRENOBLE ALPES   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c PCEBM   (France)

Author keywords

Furosemide; Human; Internal mammary arteries; Saphenous veins; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; FUROSEMIDE; INDOMETACIN; THROMBOXANE A2;

ARTERY DILATATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; HEART FAILURE; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; ISOLATED ORGAN; PRIORITY JOURNAL; SAPHENOUS VEIN; VEIN DILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; DRUG INTERACTIONS; FUROSEMIDE; HUMANS; MAMMARY ARTERIES; SAPHENOUS VEIN; THROMBOXANE A2; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 0034029085     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200004000-00003     Document Type: Article

References (6)

1. Puschett JB. Sites and mechanisms of action of diuretics in the kidney. J Clin Pharmacol 1981;21:564-74.
2. Dormans TPJ, Pickkers P, Russel FGM, Smits P. Vascular effects of loop diuretics. Cardiovasc Res 1996;32:988-97.
3. Biagt RW, Bapat BN. Frusemide in acute pulmonary oedema. Lancet 1967;1:849.
4. Christensen S, Petersen J. Effect of furosemide on renal haemodynamics and proximal tubular sodium reabsorption in conscious rats. Br J Pharmacol 1988;95:353-60.
5. Pickkers P, Dormans TPJ, Russel FGM, et al. Direct vascular effects of furosemide in humans. Circulation 1997;96:1847-52.
6. Barthelmebs M, Stephan D, Fontaine C, Grima M, Imbs JL. Vascular effects of loop diuretics: an in vivo and in vitro study in the rat. Naunyn Schmiedebergs Arch Pharmacol 1994;349:209-16.